Related references
Note: Only part of the references are listed.IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization
Helga Schneider et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The reverse stop-signal model for CTLA4 function
Christopher E. Rudd
NATURE REVIEWS IMMUNOLOGY (2008)
The tyrosine phosphatase SHP-2 regulates differentiation and apoptosis of individual T lymphocytes
Holger Hoff et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation
S. Rhiannon Jenkinson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
High IFN-γ production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4)
Pushpa Pandiyan et al.
JOURNAL OF IMMUNOLOGY (2007)
Cutting edge:: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation
Naofumi Takemoto et al.
JOURNAL OF IMMUNOLOGY (2006)
Reversal of the TCR stop signal by CTLA-4
Helga Schneider et al.
SCIENCE (2006)
IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of eomesodermin expression
Akira Suto et al.
JOURNAL OF IMMUNOLOGY (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells
MJ Townsend et al.
IMMUNITY (2004)
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
LC Bonifaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Recent developments in the transcriptional regulation of cytolytic effector cells
LH Glimcher et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
FS Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
CTLA-4: new insights into its biological function and use in tumor immunotherapy
JG Egen et al.
NATURE IMMUNOLOGY (2002)
Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells
SJ Szabo et al.
SCIENCE (2002)
T-cell regulation by CD28 and CTLA-4
ML Alegre et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen
J Hernandez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy
A van Elsas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells:: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
TF Gajewski et al.
JOURNAL OF IMMUNOLOGY (2001)
Eomesodermin is required for mouse trophoblast development and mesoderm formation
AP Russ et al.
NATURE (2000)
Share Paper
